for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Palatin Technologies Announces Reinitiation Of Enrollment Of Phase 2 Study With Pl9643 For Treatment Of Dry Eye Disease

July 8 (Reuters) - Palatin Technologies Inc:

* PALATIN TECHNOLOGIES, INC. ANNOUNCES REINITIATION OF ENROLLMENT OF PHASE 2 STUDY WITH PL9643 FOR THE TREATMENT OF DRY EYE DISEASE

* PALATIN TECHNOLOGIES INC - DATA READOUT TARGETED FOR Q4 OF CALENDAR YEAR 2020

* PALATIN TECHNOLOGIES - PATIENT ENROLLMENT FOR PL9643 PHASE 2 CLINICAL STUDY IS CURRENTLY EXPECTED TO BE COMPLETE WITHIN NEXT 30-45 DAYS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up